Terina N. Martinez

Medicine · Health Sciences

18h-index3.0kcitations29works4.52yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(15), Cellular transport and secretion(9), Nerve injury and regeneration(7), Nuclear Receptors and Signaling(5), Lysosomal Storage Disorders Research(4)

Publications29 total

Modeling Huntington’s disease progression utilizing the Huntington’s disease integrated staging system
2026Open Access
Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson’s disease-related phenotypes in a novel humanized rat model
PLoS ONE·2025Open Access
A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studies
CPT Pharmacometrics & Systems Pharmacology·2024Open Access
A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
Alzheimer s & Dementia·2024· 18 citedOpen Access
269th ENMC international workshop: 10 years of clinical trials in Duchenne muscular dystrophy – What have we learned? 9–11 December 2022, Hoofddorp, The Netherlands
Neuromuscular Disorders·2023· 6 citedOpen Access
Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
Neurotherapeutics·2023Open Access
Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
Neurotherapeutics·2023· 23 citedOpen Access
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials
CPT Pharmacometrics & Systems Pharmacology·2023· 11 citedOpen Access
The <i>GBA1</i> D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
Disease Models & Mechanisms·2022· 16 citedOpen Access
Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model
PLoS ONE·2021· 40 citedOpen Access
Abstract 5574: <i>In vivo</i> model development for immune cell-based therapeutics
Cancer Research·2020
Rab29 activation of the Parkinson's disease‐associated <scp>LRRK</scp> 2 kinase
The EMBO Journal·2019· 19 citedOpen Access
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human
Biochemical Journal·2018· 211 citedOpen Access
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents
Journal of Parkinson s Disease·2018· 291 citedOpen Access
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
The EMBO Journal·2017· 360 citedOpen Access
Development of phospho-specific Rab protein antibodies to monitor <i>in vivo</i> activity of the LRRK2 Parkinson's disease kinase
Biochemical Journal·2017· 164 citedOpen Access
Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis
eLife·2017· 496 citedOpen Access
Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils
Biochemical Journal·2017· 176 citedOpen Access
Author response: Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis
2017· 4 citedOpen Access
The hTH-GFP Reporter Rat Model for the Study of Parkinson's Disease
PLoS ONE·2014· 20 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Paweł Lis(7), Dario R. Alessi(7), Malú G. Tansey(7), Francesca Tonelli(6), Kelly A. Ruhn(6), Nicole K. Polinski(6), Herschel S. Dhekne(4), Suzanne R. Pfeffer(4), Kuldip D. Dave(4), Martin Steger(3), Federico Diez(3), Matthias Mann(3), Adil R. Sarhan(3), Melissa K. McCoy(3), Tamy C. Frank-Cannon(3), John J. Hong(3), Marian Marvin(3), Isaac Treviño(3), Bradford Casey(3), Matthew S. Goldberg(3)